Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AGMB compared with IMRX: revenue, margins and what each company keeps, and the suppliers and customers both name
AGMB
Agomab Therapeutics NV
Change
Mkt cap
Revenue
Revenue
IMRX
Immuneering Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
AGMB
Agomab Therapeutics NV
vs
IMRX
Immuneering Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
AGMB
No earnings history for AGMB.
IMRX
2 of 4 reports
0 of 2
at or beyond implied
Report
implied
realized
× implied
Oct 30 '26
±23.8%
▼
−6.84%
×0.29
Q2 FY26
±18.2%
▼
−0.23%
×0.01
= implied
AGMB realized, solid
IMRX realized, hatched
One scale, both sides: full bar = 24%
× = |realized| ÷ implied
Source: market data
AGMB
Agomab Therapeutics NV
Change
7.98
▲
+14.44%
· post 7.97
Mkt cap
$260.9M
IMRX
Immuneering Corp
Change
3.59
▲
+6.66%
· post 3.60
Closed
Nov 6 '26
Mkt cap
$238.1M
vs
Compare
Closed
Nov 6 '26
AGMB
Agomab Therapeutics NV
vs
IMRX
Immuneering Corp
7.98
▲
+14.44%
post 7.97
Price
3.59
▲
+6.66%
post 3.60
$260.9M
Mkt cap
$238.1M
Change
Change
AGMB
7.98
▲
+14.44%
vs
IMRX
3.59
▲
+6.66%
Closed
Nov 6 '26